DNA X, Inc.
SONM
$3.94
-$0.54-12.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 38.61% | -149.38% | -200.96% | -839.62% | -37,286.67% |
| Total Depreciation and Amortization | 20.89% | 158.19% | 525.47% | 1,156.57% | 7,468.09% |
| Total Amortization of Deferred Charges | -68.11% | -19.07% | -19.07% | 200.32% | 200.32% |
| Total Other Non-Cash Items | -185.91% | -145.93% | -114.50% | -128.19% | 125.56% |
| Change in Net Operating Assets | -149.45% | 172.47% | 285.85% | 293.42% | 223.90% |
| Cash from Operations | -177.23% | -501.46% | -360.59% | -597,366.67% | -109.43% |
| Capital Expenditure | -- | 96.33% | -76.83% | -178.79% | -494.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 96.33% | -76.83% | -178.79% | -494.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -1,497.30% | -698.65% | -- | -- |
| Issuance of Common Stock | 237.14% | 264.17% | 115.83% | 1,497.25% | 867.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 319.41% | 401.86% | 186.45% | 2,930.66% | 1,608.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.35% | -839.35% | -6,228.33% | -2,535.84% | -6.24% |